Zinc transporter-3 (ZnT3) protein is responsible for loading zinc into presynaptic vesicles and consequently controls the availability of zinc at the glutamatergic synapse. ZnT3 has been shown to decline with age and in Alzheimer's disease (AD) and is crucially involved in learning and memory. In this study, we utilised whole animal behavioural analyses in the ZnT3 KO mouse line, together with electrophysiological analysis of long-term potentiation in brain slices from ZnT3 KO mice, to show that metal chaperones (clioquinol, 30 mg/kg/day for 6 weeks) can prevent the age-dependent cognitive phenotype that characterises these animals. This likely occurs as a result of a homeostatic restoration of synaptic protein expression, as clioquinol significantly restored levels of various pre-and postsynaptic proteins that are critical for normal cognition, including PSD-95; AMPAR and NMDAR2b. We hypothesised that this clioquinol-mediated restoration of synaptic health resulted from a selective increase in synaptic zinc content within the hippocampus. While we demonstrated a small regional increase in hippocampal zinc content using synchrotron x-ray fluorescence microscopy, further sub-region analyses are required to determine whether this effect is seen in other regions of the hippocampal formation that are more closely linked to the synaptic plasticity effects observed in this study. These data support our recent report on the use of a different metal chaperone (PBT2) to prevent normal age-related cognitive decline and demonstrate that metal chaperones are efficacious in preventing the zinc-mediated cognitive decline that characterises ageing and disease.
Introduction
The underlying mechanisms of cognitive loss in aging and Alzheimer's disease (AD) have largely remained uncertain. Recent evidence implicates presynaptic Zn 2+ , released with glutamate and loaded into vesicles by Zinc Transporter-3 (ZnT3), in both the formation of the hallmark β-amyloid accumulation of AD (Lee et al., 2002) and in normal cognitive function (Adlard et al., 2010) . ZnT3 allows Zn 2+ to achieve high micromolar concentrations during activity within the glutamatergic synapses governing memory and learning (Frederickson et al., 2006) . This Zn 2+ may influence the neurochemistry of cognition by acting as a neuronal messenger and a modulator of synaptic transmission and plasticity (Frederickson et al., 2005) et al., 2008) . Indeed, the targeted ablation of ZnT3 in wild-type mice results in an impairment in cognitive function that is paralleled by deficits in key proteins involved in synaptic plasticity pathways (Adlard et al., 2010) . This led us to hypothesise that ZnT3 KO mice are a phenocopy of the synaptic and memory deficits of AD and potentially also of normal ageing. In this study, we have addressed the hypothesis that the use of metal chaperones will restore metal ion homeostasis within the hippocampus of ZnT3 KO mice to result in a concomitant normalisation of key biochemical pathways involved in cognition and subsequent amelioration of the cognitive loss that characterises this model.
Materials and methods

Animal tissues
ZnT3 KO and WT animals were housed in the Animal Facility at the Mental Health Research Institute. All animal experimentation was approved by the Howard Florey Animal Ethics Committee and conformed to Code of Practice established by the National Health and Medical Research Council of Australia for the Care and Use of Animals for Scientific Purposes (7th Edition, 2004) . Neurobiology of Disease 81 (2015) 196-202 
